9 November 2023 in PLOS Global Public Health
Tracheostomy is a lifesaving, essential procedure performed for airway obstruction in the case of head and neck cancers, prolonged ventilator use, and for long-term pulmonary care. While successful quality improvement interventions in high-income countries such as through the Global Tracheostomy Collaborative significantly reduced length of hospital stay and decreased levels of anxiety among patients, limited literature exists regarding tracheostomy care and practices in low and middle-income countries (LMIC), where most of the world resides. Given limited literature, this scoping review aims to summarize published tracheostomy studies in LMICs and highlight areas in need of quality improvement and clinical research efforts. Based on the PRISMA guidelines, a scoping review of the literature was performed through MEDLINE/PubMed and Embase using terms related to tracheostomy, educational and quality improvement interventions, and LMICs. Publications from 2000–2022 in English were included. Eighteen publications representing 10 countries were included in the final analysis. Seven studies described baseline needs assessments, 3 development of training programs for caregivers, 6 trialed home-based or hospital-based interventions, and finally 2 articles discussed development of standardized protocols. Overall, studies highlighted the unique challenges to tracheostomy care in LMICs including language, literacy barriers, resource availability (running water and electricity in patient homes), and health system access (financial costs of travel and follow-up). There is currently limited published literature on tracheostomy quality improvement and care in LMICs. Opportunities to improve quality of care include increased efforts to measure complications and outcomes, implementing evidence-based interventions tailored to LMIC settings, and using an implementation science framework to study tracheostomy care in LMICs.
1 December 2021 in JCO Global Oncology
EAEmmanuel Amankwaa-Frempong
Emmanuel Amankwaa-Frempong
+9
1 November 2020 in JCO Global Oncology
PURPOSE: Albinism affects some facets of the eye’s function and coloration, as well as hair and skin color. The prevalence of albinism is estimated to be one in 2,000-5,000 people in sub-Saharan Africa and one in 270 in Tanzania. People in Tanzania with albinism experience sociocultural and economic disparities. Because of stigma related to albinism, they present to hospitals with advanced disease, including skin cancers. Mobile health (mHealth) can help to bridge some of the gaps in detection and treatment of skin cancers affecting this population. METHODS: We assessed the feasibility of using a mobile application (app) for detection of skin cancers among people with albinism. The study was approved by the Ocean Road Cancer Institute institutional review board. Data, including pictures of the lesions, were collected using a mobile smartphone and submitted to expert reviewers. Expert reviewers’ diagnosis options were benign, malignant, or unevaluable. RESULTS: A total of 77 lesions from different body locations of 69 participants were captured by the NgoziYangu mobile app. Sixty-two lesions (81%) were considered malignant via the app and referred for biopsy and histologic diagnosis. Of those referred, 55 lesions (89%) were biopsied, and 47 lesions (85%) were confirmed as skin malignancies, whereas eight (15%) were benign. CONCLUSION: With an increasing Internet coverage in Africa, there is potential for smartphone apps to improve health care delivery channels. It is important that mobile apps like NgoziYangu be explored to reduce diagnostic delay and improve the accuracy of detection of skin cancer, especially in stigmatized groups.
11 November 2025 in The Oncologist
JKJesse Jonathan Kashabano
+6
Purpose: Breast cancer is a heterogeneous disease with a wide spectrum of subtypes, each with distinct biological features. Data on tumor subtypes in East Africa are sparse despite the rising incidence of breast cancer in this region. We aimed to determine the prevalence of triple-negative breast cancer (TNBC) and to compare clinicopathological features, overall survival (OS), and factors affecting OS of patients with TNBC and non-TNBC in Tanzania. Methods: This retrospective nested case–control study included patients with histologically proven breast cancer treated at Ocean Road Cancer Institute (ORCI) in Tanzania from January 2018 to December 2019. Logistic regression was used to determine factors associated with TNBC, and Cox proportional hazards regression was used to determine the factors independently associated with overall survival. Results: TNBC constituted 23.3% of all breast cancer diagnoses. Patients in the TNBC group were younger (median age 46 vs 53 years, P < .001) and more often presented with stage IV disease (12% vs 4%, P = .001). Three-year OS was significantly lower in the TNBC group (36%) compared to the non-TNBC group (57%) (P = .004) and remained lower for the TNBC group across every tumor stage. Brain metastasis was higher in the TNBC group (34% vs 7%, P < .001). Factors associated with improved survival included shorter symptom duration (0.53 [0.36-0.78]), earlier stage (0.23 [0.12-0.46]), use of neoadjuvant chemotherapy (0.59 [0.40-0.86]), and surgery with clean margins (0.34 [0.19-0.60]). Conclusions: TNBC accounted for nearly a quarter of the breast cancers at ORCI. TNBC was associated with younger age, more aggressive clinicopathologic features, and worse survival. Efforts toward earlier diagnosis and optimized therapies will be critical to improving TNBC outcomes in Tanzania.
9 November 2023 in The Breast
30 September 2026 in Tanzania Medical Journal
JKJesse Jonathan Kashabano
Background: Laryngeal cancer (LC) represents the most common head and neck squamous cell carcinoma in Tanzania. Although global trends demonstrate declining incidence and improving outcomes, survival disparities remain substantial, largely driven by inequities in access to definitive surgical care and the increasing adoption of organ preservation strategies. In low- and middle-income countries, delayed presentation and limited access to multimodal treatment continue to affect outcomes adversely. This study aimed to identify factors associated with 5-year overall survival (OS) among patients with LC managed at a tertiary cancer center in Dar es Salaam, Tanzania, within the context of organ–preservation–based therapy. Methods: A retrospective cohort study was conducted at the Ocean Road Cancer Institute (ORCI). Medical records of 82 patients diagnosed with LC and treated between 2008 and 2012 were reviewed. The primary outcome was 5-year OS. Survival probabilities were estimated using the Kaplan–Meier method. The log-rank test was used for univariate comparisons, and multivariate analysis was performed using Cox proportional hazards regression. Results: Laryngeal squamous cell carcinoma accounted for 99% of cases and predominantly affected males (male-to-female ratio 10:1), with a mean age of 61 years. Hoarseness was the most common presenting symptom (90.2%). Most patients (72.3%) presented with advanced disease (stage III–IV). The 5-year overall survival was 29%. In multivariable Cox proportional hazards analysis, supraglottic tumor location remained independently associated with worse overall survival compared with glottic tumors (adjusted HR [aHR] 2.13, 95% CI 1.16–3.91, p = 0.015). Treatment-related factors were independently associated with improved survival, including receipt of an EQD2 dose ≥46 Gy (aHR 0.50, 95% CI 0.26–0.97, p = 0.041) and CCRT (aHR 0.46, 95% CI 0.23–0.92, p = 0.029. Conclusion: The 5-year OS was 29%. Poor survival was independently associated with supraglottic tumor location, absence of concurrent chemotherapy, and lower total RT dose. These findings underscore the importance of optimizing definitive treatment in this setting, particularly through appropriate RT dose escalation and broader use of concurrent chemoradiotherapy. Where feasible, carefully selected patients may also benefit from timely salvage laryngectomy within an organ preservation framework to improve long-term disease control.